AGAINST BREAST CANCER LIMITED
Against Breast Cancer funds a research programme into the treatment and prevention of breast cancer, focusing particularly on secondary spread and survival after diagnosis.We are leading the worlds largest study into the diet and lifestyle of breast cancer patients.Our Research Teams quest to produce a breast cancer vaccine and ultimately a cure for breast cancer.
Objects
FOR THE PUBLIC BENEFIT TO ADVANCE EDUCATION BY CONDUCTING OR COMMISSIONING RESEARCH INTO THE CAUSES AND TREATMENT OF CANCER, PRIMARILY SECONDARY SPREAD BREAST CANCER, AND TO PUBLISH THE RESULTS THEREOF.
Financial health, per its FY2024 accounts
The accounts state that the charity achieved a net income of £104,179 for the year ended 31 December 2024, a significant improvement from the previous year's loss. The trustees report that the charity remains committed to financial growth and stability, with total reserves increasing to £458,168. The auditor confirmed that the financial statements are prepared on a going concern basis with no material uncertainties identified.
What the accounts disclose
“Against Breast Cancer decided on a policy of holding 3 to 6 months operating costs. A figure of £150,000 was considered to be a reasonable level of reserves to be held that would enable the charity to meet all of its liabilities should operations have to cease at some point in the future.” — page 13
“At 31st December 2024 the Charity was owed £62,107 (2023: £64,599) by its 100% owned subsidiary, Against Breast Cancer Trading Limited as a result of trade charges, and charity income received by the subsidiary less expenditure incurred on the subsidiary's behalf.” — page 34
“At 31st December 2024 the Charity owed £1 (2023: £nil) to its 100% owned subsidiary, Against Breast Cancer Trading Limited as a result of trade charges, and charity income received by the subsidiary less expenditure incurred on the subsidiary's behalf.” — page 34
“At 31st December 2024 the Charity was owed £62,107 (2023: £64,599) by its 100% owned subsidiary, Against Breast Cancer Trading Limited as a result of trade charges, and charity income received by the subsidiary less expenditure incurred on the subsidiary's behalf.” — page 34
“At 31st December 2024 the Charity owed £1 (2023: £nil) to its 100% owned subsidiary, Against Breast Cancer Trading Limited as a result of trade charges, and charity income received by the subsidiary less expenditure incurred on the subsidiary's behalf.” — page 34
Policies the charity declares
- Bullying and harassment policy and procedures
- Campaigns and political activity policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
Leadership, per the charity’s website
- Dr Anthony Leathem — Founder
Property (HM Land Registry)
Structured financials (annual return, FY ending 31/12/2024)
Trustees
- RICHARD BAHUchair
- Dennis Remoundos
- JEANNE CATHERINE CHATTOE
- Jennifer Collins
- Laura Hounam Mrs
- Naomi Webb
- Victoria Harmer
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £1.1m | £974k |
| 31/12/2023 | £1.1m | £1.2m |
| 31/12/2022 | £875k | £858k |
| 31/12/2021 | £755k | £912k |
| 31/12/2020 | £798k | £985k |
Common questions
Is AGAINST BREAST CANCER LIMITED financially healthy?
Per its FY2024 accounts: The accounts state that the charity achieved a net income of £104,179 for the year ended 31 December 2024, a significant improvement from the previous year's loss. The trustees report that the charity remains committed to financial growth and stability, with total reserves increasing to £458,168. The auditor confirmed that the financial statements are prepared on a going concern basis with no material uncertainties identified. Its FY2024 accounts were audited by Xeinadin Audit Limited.
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| The National Lottery Community Fund | 28/10/2010 | £6k | Updating Office IT Equipment |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| PINK RIBBON FOUNDATION | 3 | £30k |
| THE TIM BACON FOUNDATION | 2 | £195k |
| ASSOCIATION OF BREAST SURGERY | 2 | £117k |
| THE GEOFFREY AND PAULINE MARTIN TRUST | 2 | £20k |
| THE WILLIAM ALLEN YOUNG CHARITABLE TRUST | 2 | £12k |
| MILLS AND REEVE CHARITABLE TRUST | 2 | £7k |
| COL-RENO LIMITED | 2 | £4k |
| GOWLING WLG (UK) CHARITABLE TRUST | 2 | £3k |
Charities like this
- Prevent Breast Cancer
- BREAST CANCER RESEARCH AID (BCRA)
- LADIES FIGHTING BREAST CANCER CHARITABLE TRUST
- BREAST CANCER UK LIMITED
- BREAST CANCER NOW
- BREAST CANCER KENT
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| AGAINST BREAST CANCER LIMITED | £1.1m | — | 0 | unclear | — | no doubt |
| Prevent Breast Cancer | £2.2m | — | — | unclear | — | no doubt |
| BREAST CANCER RESEARCH AID (BCRA) | £123k | — | 0 | unclear | — | no doubt |
| LADIES FIGHTING BREAST CANCER CHARITABLE TRUST | £233k | — | 0 | unclear | — | no doubt |
| BREAST CANCER UK LIMITED | £2.1m | — | 0 | above | 17.7% | no doubt |
| BREAST CANCER NOW | £59.3m | — | — | unclear | — | no doubt |